Sale!

Peter Addy – PESI – Psychedelics, Hallucinogens and Entheogens What Clinicians Need to Know

$22

INSTANT DELIVERY !!!

Please check your email ( spam, junk box) after your order

Link will be sent to you in a hour

Description

Description

Peter Addy – PESI – Psychedelics, Hallucinogens and Entheogens What Clinicians Need to Know download, Peter Addy – PESI – Psychedelics, Hallucinogens and Entheogens What Clinicians Need to Know review, Peter Addy – PESI – Psychedelics, Hallucinogens and Entheogens What Clinicians Need to Know free

Peter Addy – PESI – Psychedelics, Hallucinogens and Entheogens What Clinicians Need to Know

Speaker: Peter H Addy, PhD, LPC, LMHC

Duration: 6 Hours 17 Minutes

Format: Audio and Video

Copyright: Jul 15, 2020

Media Type: Digital Seminar

Description

Would you be able to spot your clients’ recreational use of psychedelics? What does psychedelic use mean for them (and you) in therapy? Would any of your clients benefit from a psychedelic experience? How will you know? How will you navigate the ethical dilemmas that may arise in session?

Many of us were taught nothing about psychedelics, or were given out-of-date information based on early Prohibition era stories and policies. Psychedelic-assisted psychotherapy is effective in the treatment of a variety of mental health conditions, and the FDA has both approved phase III clinical trials and expanded access. But there are gaps between clinician awareness of psychedelic use, how psychedelics are used in carefully designed clinical trials, and how your clients use them in the real world.

Complete this online training to bridge those gaps and confidently address your clients’ questions and experiences. You’ll acquire the skills you need to navigate common ethical dilemmas that may arise from talking with your clients about possibly illegal activity.

By completing this course, you’ll discover why clients use psychedelic substances and how this may impact their treatment.

In this workshop, you will learn:

  • Types of psychedelic substances & their effects
  • How & why psychedelics are used
  • How to talk to your clients about psychedelic substances
  • Updates on research of the effectiveness of psychedelics

Purchase today, and get need-to-know information on psychedelic substances, a better understanding of the research and navigate these changing times!

Speaker

Peter H Addy, PhD, LPC, LMHC

Peter H Addy, PhD, LPC, LMHC, has studied psychedelic substances and states and consciousness for 15 years. He earned a PhD in clinical psychology studying transcendence, wholeness, and transformation and conducted one of the earliest studies of the atypical psychedelic plant Salvia divinorum in humans. He continued refining his research and clinical skills at Yale University where he studied Salvia and other atypical psychedelics and co-founded the Yale Psychedelic Science Group. He has completed postdoctoral training in substance use disorder treatment, participated in non-directive harm reduction and integration training at Burning Man, and traveled to Mexico to learn about indigenous use of psychedelic plants among the Mazatec people. He is currently a psychotherapist in private practice in Washington and Oregon.

Dr. Addy has presented internationally on a variety of subjects related to spirituality and transpersonal states, psychedelic science, and research methodology. Participants consistently regarded his talks as informative, accessible, and humorous. He has written numerous scientific articles, book chapters, and popular press articles on typical and atypical psychedelics, substance abuse, and spirituality.

Speaker Disclosures:
Financial: Dr. Peter Addy maintains a private practice, and he has an employment relationship with the Synaptic Training Institute. receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Peter Addy has no relevant non-financial relationships.

Objectives

  1. Analyze known mechanisms of action for psychedelics, MDMA, and dissociatives as they relate to case conceptualization.
  2. Evaluate recent clinical trials, other research on psychedelics, and their treatment implications.
  3. Determine contraindications to using psychedelics in therapy, as well as other potential risks of use.
  4. Appraise the basic concepts of psychedelic integration as related to clinical treatment.
  5. Utilize clinical strategies to talk about psychedelics when your clients bring up their experiences in session.
  6. Analyze the ethical challenges that may arise when discussing use of psychedelics in session.

Outline

Types of Psychedelic Substances: What You Need to Know

  • Classic Psychedelics: LSD, Psilocybin, Mescaline, DMT
  • Empathogens: MDMA
  • Dissociatives: Ketamine, Dextromethorphan, Nitrous Oxide
  • Complex Psychedelics: Ayahuasca, Ibogaine
  • Other Atypical Psychedelics: Salvia Divinorum, Cannabis

History & Context of Psychedelic Use: The Research

  • Epidemiology: Who uses, how, & how often
  • Pharmacology: How they work in the brain
  • Indigenous Use: How they work in culture
  • Safety
  • Addiction to psychedelics
  • MDMA is not ecstasy
  • Potency & purity of “street drugs”
  • Ibogaine & cardiac toxicity
  • Contemporary Research
  • PTSD
  • Addiction
  • End-of-life anxiety
  • Depression
  • OCD
  • Social anxiety

Legal Avenues for Experiencing Psychedelics: Paths Clients May Take

  • Clinical Trials for MDMA & psilocybin
  • Cultural Tourism
  • South American ayahuasca tourism
  • Central American mushroom tourism
  • Contemporary Tourism
  • Mushroom tourism in the Netherlands, Jamaica
  • Church for ayahuasca & peyote
  • Legal Psychedelics
  • Ketamine & cannabis clinics
  • The strange case of Salvia
  • Exercise: Discuss psychedelics with your client

Ethical Considerations for Your Clients

  • Sexual abuse in psychedelics communities
  • Outing & societal pushback
  • Isolation when your client has no community
  • Limitations of the related research

Ethical Considerations in the Therapy Room

  • Assessment strategies to determine high risk
  • The entropic brain theory
  • Diagnoses that may benefit from psychedelic experiences
  • How to talk about future illegal activity
  • Spiritual bypassing: Using psychedelics to avoid working on yourself
  • Exercise: Navigate ethical challenges

Psychotherapy Preparation & Integration

  • Non-directive counseling
  • Grounding techniques
  • The holotropic mind model
  • Exercise: Practice counseling techniques

Target Audience

  • Addiction Counselors
  • Case Managers
  • Counselors
  • Marriage and Family Therapists
  • Nurses
  • Psychologists
  • Psychotherapists
  • Social Workers
  • Therapists
  • Psychiatrists
  • Other Mental Health Professionals

Frequently Asked Questions:

  1. Innovative Business Model:
    • Embrace the reality of a genuine business! Our approach involves forming a group buy, where we collectively share the costs among members. Using these funds, we purchase sought-after courses from sale pages and make them accessible to individuals facing financial constraints. Despite potential reservations from the authors, our customers appreciate the affordability and accessibility we provide.
  2. The Legal Landscape: Yes and No:
    • The legality of our operations falls into a gray area. While we lack explicit approval from the course authors for resale, there’s a technicality at play. When procuring the course, the author didn’t specify any restrictions on resale. This legal nuance presents both an opportunity for us and a boon for those seeking budget-friendly access.
  3. Quality Assurance: Unveiling the Real Deal:
    • Delving into the heart of the matter – quality. Acquiring the course directly from the sale page ensures that all documents and materials are identical to those obtained through conventional means. However, our differentiator lies in going beyond personal study; we take an extra step by reselling. It’s important to note that we are not the official course providers, meaning certain premium services aren’t included in our package:
      • No coaching calls or scheduled sessions with the author.
      • No access to the author’s private Facebook group or web portal.
      • No entry to the author’s exclusive membership forum.
      • No direct email support from the author or their team.

    We operate independently, aiming to bridge the affordability gap without the additional services offered by official course channels. Your understanding of our unique approach is greatly appreciated.

Refund is acceptable:

  • Firstly, item is not as explained
  • Secondly, Item do not work the way it should.
  • Thirdly, and most importantly, support extension can not be used.

Thank you for choosing us! We’re so happy that you feel comfortable enough with us to forward your business here.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Peter Addy – PESI – Psychedelics, Hallucinogens and Entheogens What Clinicians Need to Know”

Your email address will not be published.